The exacerbation of colitis observed in Rnase4-deficient mice, as well as the association between Rnase4 and gut microbiota dysbiosis, imply possible clinical potential of RNASE4 in IBD management, including Ulcerative colitis (UC) and Crohn’s disease (CD). This evidence concerns the gene RNASE4 and irritable bowel syndrome.